Alpha-synuclein deficiency in the C57BL/6JOlaHsd strain does not modify disease progression in the ME7-model of prion disease

Neuroscience

Volumn 165, Issue 3, 2010, Pages 662-674

  Asuni, A A ^a   Hilton, K ^a   Siskova, Z ^a   Lunnon, K ^a   Reynolds, R ^a   Perry, V H ^a   O'Connor, V ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

C57BL 6JCrl; C57BL 6JOlaHsd; neurodegeneration; spontaneous deletion; synaptopathy

Indexed keywords

ALPHA SYNUCLEIN; PRION PROTEIN;

ALPHA SYNUCLEIN DEFICIENCY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASTROCYTOSIS; BEHAVIOR DISORDER; C57BL 6 MOUSE; CONTROLLED STUDY; DISEASE MODEL; GENE DELETION; HIPPOCAMPUS; MOUSE; NEUROPATHOLOGY; NONHUMAN; PRION DISEASE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN FOLDING; SCRAPIE AGENT; STRAIN DIFFERENCE; WILD TYPE;

ALPHA-SYNUCLEIN; ANIMALS; BEHAVIOR, ANIMAL; COHORT STUDIES; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMALE; HIPPOCAMPUS; MICE; MICE, INBRED C57BL; PRPSC PROTEINS; RANDOM ALLOCATION; SCRAPIE; SPECIES SPECIFICITY; SYNAPSES; TIME FACTORS;

EID: 72749113927     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2009.10.047     Document Type: Article

References (63)

1. Asuni A.A., Cunningham C., Vigneswaran P., Perry V.H., and O'Connor V. Unaltered SNARE complex formation in an in vivo model of prion disease. Brain Res 1233 (2008) 1-7
2. Bachmanov A.A., Reed D.R., Beauchamp G.K., and Tordoff M.G. Food intake, water intake, and drinking spout side preference of 28 mouse strains. Behav Genet 32 (2002) 435-443
3. Belichenko P.V., Brown D., Jeffrey M., and Fraser J.R. Dendritic and synaptic alterations of hippocampal pyramidal neurones in scrapie-infected mice. Neuropathol Appl Neurobiol 26 (2000) 143-149
4. Bellusci S., Henderson R., Winnier G., Oikawa T., and Hogan B.L. Evidence from normal expression and targeted misexpression that bone morphogenetic protein (Bmp-4) plays a role in mouse embryonic lung morphogenesis. Development (Cambridge, England) 122 (1996) 1693-1702
5. Broom K.A., Anthony D.C., Lowe J.P., Griffin J.L., Scott H., Blamire A.M., Styles P., Perry V.H., and Sibson N.R. MRI and MRS alterations in the preclinical phase of murine prion disease: association with neuropathological and behavioural changes. Neurobiol Dis 26 (2007) 707-717
6. Chandra S., Fornai F., Kwon H.B., Yazdani U., Atasoy D., Liu X., Hammer R.E., Battaglia G., German D.C., Castillo P.E., and Sudhof T.C. Double-knockout mice for alpha- and beta-synucleins: effect on synaptic functions. Proc Natl Acad Sci U S A 101 (2004) 14966-14971
7. Chandra S., Gallardo G., Fernandez-Chacon R., Schluter O.M., and Sudhof T.C. Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration. Cell 123 (2005) 383-396
8. Chiti Z., Knutsen O.M., Betmouni S., and Greene J.R. An integrated, temporal study of the behavioural, electrophysiological and neuropathological consequences of murine prion disease. Neurobiol Dis 22 (2006) 363-373
9. Cunningham C., Deacon R., Wells H., Boche D., Waters S., Diniz C.P., Scott H., Rawlins J.N., and Perry V.H. Synaptic changes characterize early behavioural signs in the ME7 model of murine prion disease. Eur J Neurosci 17 (2003) 2147-2155
10. Cunningham C., Deacon R.M., Chan K., Boche D., Rawlins J.N., and Perry V.H. Neuropathologically distinct prion strains give rise to similar temporal profiles of behavioral deficits. Neurobiol Dis 18 (2005) 258-269
11. Deacon R.M., Bannerman D.M., Kirby B.P., Croucher A., and Rawlins J.N. Effects of cytotoxic hippocampal lesions in mice on a cognitive test battery. Behav Brain Res 133 (2002) 57-68
12. Deacon R.M., Raley J.M., Perry V.H., and Rawlins J.N. Burrowing into prion disease. Neuroreport 12 (2001) 2053-2057
13. Dell'Omo G., Vannoni E., Vyssotski A.L., Di Bari M.A., Nonno R., Agrimi U., and Lipp H.P. Early behavioural changes in mice infected with BSE and scrapie: automated home cage monitoring reveals prion strain differences. Eur J Neurosci 16 (2002) 735-742
14. Fein J.A., Sokolow S., Miller C.A., Vinters H.V., Yang F., Cole G.M., and Gylys K.H. Co-localization of amyloid beta and tau pathology in Alzheimer's disease synaptosomes. Am J Pathol 172 (2008) 1683-1692
15. Fernandez-Chacon R., Wolfel M., Nishimune H., Tabares L., Schmitz F., Castellano-Munoz M., Rosenmund C., Montesinos M.L., Sanes J.R., Schneggenburger R., and Sudhof T.C. The synaptic vesicle protein CSP alpha prevents presynaptic degeneration. Neuron 42 (2004) 237-251
16. Fuhrmann M., Mitteregger G., Kretzschmar H., and Herms J. Dendritic pathology in prion disease starts at the synaptic spine. J Neurosci 27 (2007) 6224-6233
17. Gajovic S., Mitrecic D., Augustincic L., Iaconcig A., and Muro A.F. Unexpected rescue of alpha-synuclein and multimerin1 deletion in C57BL/6JOlaHsd mice by beta-adducin knock out. Transgenic Res 15 (2006) 255-259
18. Gray B.C., Siskova Z., Perry V.H., and O'Connor V. Selective presynaptic degeneration in the synaptopathy associated with ME7-induced hippocampal pathology. Neurobiol Dis 35 1 (2009) 63-74
19. Gray B.C., Skipp P., O'Connor V.M., and Perry V.H. Increased expression of glial fibrillary acidic protein fragments and mu-calpain activation within the hippocampus of prion-infected mice. Biochem Soc Trans 34 (2006) 51-54
20. Guenther K., Deacon R.M., Perry V.H., and Rawlins J.N. Early behavioural changes in scrapie-affected mice and the influence of dapsone. Eur J Neurosci 14 (2001) 401-409
21. Gylys K.H., Fein J.A., Yang F., Wiley D.J., Miller C.A., and Cole G.M. Synaptic changes in Alzheimer's disease: increased amyloid-beta and gliosis in surviving terminals is accompanied by decreased PSD-95 fluorescence. Am J Pathol 165 (2004) 1809-1817
22. Herms J., Tings T., Gall S., Madlung A., Giese A., Siebert H., Schurmann P., Windl O., Brose N., and Kretzschmar H. Evidence of presynaptic location and function of the prion protein. J Neurosci 19 (1999) 8866-8875
23. Jeffrey M., Fraser J.R., Halliday W.G., Fowler N., Goodsir C.M., and Brown D.A. Early unsuspected neuron and axon terminal loss in scrapie-infected mice revealed by morphometry and immunocytochemistry. Neuropathol Appl Neurobiol 21 (1995) 41-49
24. Jeffrey M., Halliday W.G., Bell J., Johnston A.R., MacLeod N.K., Ingham C., Sayers A.R., Brown D.A., and Fraser J.R. Synapse loss associated with abnormal PrP precedes neuronal degeneration in the scrapie-infected murine hippocampus. Neuropathol Appl Neurobiol 26 (2000) 41-54
25. Jeffrey M., Martin S., Barr J., Chong A., and Fraser J.R. Onset of accumulation of PrPres in murine ME7 scrapie in relation to pathological and PrP immunohistochemical changes. J Comp Pathol 124 (2001) 20-28
26. Jeffrey M., McGovern G., Martin S., Goodsir C.M., and Brown K.L. Cellular and sub-cellular localisation of PrP in the lymphoreticular system of mice and sheep. Arch Virol Suppl (2000) 23-38
27. Kempermann G., Chesler E.J., Lu L., Williams R.W., and Gage F.H. Natural variation and genetic covariance in adult hippocampal neurogenesis. Proc Natl Acad Sci U S A 103 (2006) 780-785
28. Kim T.D., Paik S.R., Yang C.H., and Kim J. Structural changes in alpha-synuclein affect its chaperone-like activity in vitro. Protein Sci 9 (2000) 2489-2496
29. Kovacs G.G., and Budka H. Prion diseases: from protein to cell pathology. Am J Pathol 172 (2008) 555-565
30. Larsen K.E., Schmitz Y., Troyer M.D., Mosharov E., Dietrich P., Quazi A.Z., Savalle M., Nemani V., Chaudhry F.A., Edwards R.H., Stefanis L., and Sulzer D. Alpha-synuclein overexpression in PC12 and chromaffin cells impairs catecholamine release by interfering with a late step in exocytosis. J Neurosci 26 (2006) 11915-11922
31. Li J., Jiang T., Mao J.H., Balmain A., Peterson L., Harris C., Rao P.H., Havlak P., Gibbs R., and Cai W.W. Genomic segmental polymorphisms in inbred mouse strains. Nat Genet 36 (2004) 952-954
32. Li J.Y., Henning Jensen P., and Dahlstrom A. Differential localization of alpha-, beta- and gamma-synucleins in the rat CNS. Neuroscience 113 (2002) 463-478
33. Morris R.J., Parkyn C.J., and Jen A. Traffic of prion protein between different compartments on the neuronal surface, and the propagation of prion disease. FEBS Lett 580 (2006) 5565-5571
34. Murphy D.D., Rueter S.M., Trojanowski J.Q., and Lee V.M. Synucleins are developmentally expressed, and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons. J Neurosci 20 (2000) 3214-3220
35. Naggert J.K., Mu J.L., Frankel W., Bailey D.W., and Paigen B. Genomic analysis of the C57BL/Ks mouse strain. Mamm Genome 6 (1995) 131-133
36. Nakajo S., Tsukada K., Omata K., Nakamura Y., and Nakaya K. A new brain-specific 14-kDa protein is a phosphoprotein. Its complete amino acid sequence and evidence for phosphorylation. Eur J Biochem 217 (1993) 1057-1063
37. O'Shea M., Maytham E.G., Linehan J.M., Brandner S., Collinge J., and Lloyd S.E. Investigation of mcp1 as a quantitative trait gene for prion disease incubation time in mouse. Genetics 180 (2008) 559-566
38. Pollak D.D., John J., Schneider A., Hoeger H., and Lubec G. Strain-dependent expression of signaling proteins in the mouse hippocampus. Neuroscience 138 (2006) 149-158
39. Pollak D.D., Scharl T., Leisch F., Herkner K., Villar S.R., Hoeger H., and Lubec G. Strain-dependent regulation of plasticity-related proteins in the mouse hippocampus. Behav Brain Res 165 (2005) 240-246
40. Polymeropoulos M.H., Lavedan C., Leroy E., Ide S.E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E.S., Chandrasekharappa S., Athanassiadou A., Papapetropoulos T., Johnson W.G., Lazzarini A.M., Duvoisin R.C., Di Iorio G., Golbe L.I., and Nussbaum R.L. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276 (1997) 2045-2047
41. Prusiner S.B. Molecular biology and pathogenesis of prion diseases. Trends Biochem Sci 21 (1996) 482-487
42. Rampon C., Jiang C.H., Dong H., Tang Y.P., Lockhart D.J., Schultz P.G., Tsien J.Z., and Hu Y. Effects of environmental enrichment on gene expression in the brain. Proc Natl Acad Sci U S A 97 (2000) 12880-12884
43. Rampon C., and Tsien J.Z. Genetic analysis of learning behavior-induced structural plasticity. Hippocampus 10 (2000) 605-609
44. Sarnataro D., Campana V., Paladino S., Stornaiuolo M., Nitsch L., and Zurzolo C. PrP(C) association with lipid rafts in the early secretory pathway stabilizes its cellular conformation. Mol Biol Cell 15 (2004) 4031-4042
45. Schluter O.M., Fornai F., Alessandri M.G., Takamori S., Geppert M., Jahn R., and Sudhof T.C. Role of alpha-synuclein in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice. Neuroscience 118 (2003) 985-1002
46. Schmitz F., Tabares L., Khimich D., Strenzke N., de la Villa-Polo P., Castellano-Munoz M., Bulankina A., Moser T., Fernandez-Chacon R., and Sudhof T.C. CSPalpha-deficiency causes massive and rapid photoreceptor degeneration. Proc Natl Acad Sci U S A 103 (2006) 2926-2931
47. Scott J.R., Jeffrey M., and Halliday W.G. Unsuspected early neuronal loss in scrapie-infected mice revealed by morphometric analysis. Ann N Y Acad Sci 724 (1994) 338-343
48. Singleton A., Gwinn-Hardy K., Sharabi Y., Li S.T., Holmes C., Dendi R., Hardy J., Singleton A., Crawley A., and Goldstein D.S. Association between cardiac denervation and parkinsonism caused by alpha-synuclein gene triplication. Brain 127 (2004) 768-772
49. Snijders A.M., Nowak N.J., Huey B., Fridlyand J., Law S., Conroy J., Tokuyasu T., Demir K., Chiu R., Mao J.H., Jain A.N., Jones S.J., Balmain A., Pinkel D., and Albertson D.G. Mapping segmental and sequence variations among laboratory mice using BAC array CGH. Genome Res 15 (2005) 302-311
50. Souza J.M., Giasson B.I., Lee V.M., and Ischiropoulos H. Chaperone-like activity of synucleins. FEBS Lett 474 (2000) 116-119
51. Specht C.G., and Schoepfer R. Deletion of the alpha-synuclein locus in a subpopulation of C57BL/6J inbred mice. BMC Neurosci 2 (2001) 11
52. Specht C.G., and Schoepfer R. Deletion of multimerin-1 in alpha-synuclein-deficient mice. Genomics 83 (2004) 1176-1178
53. Spillantini M.G., Crowther R.A., Jakes R., Hasegawa M., and Goedert M. Alpha-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies. Proc Natl Acad Sci U S A 95 (1998) 6469-6473
54. Stevens J.C., Banks G.T., Festing M.F., and Fisher E.M. Quiet mutations in inbred strains of mice. Trends Mol Med 13 (2007) 512-519
55. Totterdell S., Hanger D., and Meredith G.E. The ultrastructural distribution of alpha-synuclein-like protein in normal mouse brain. Brain Res 1004 (2004) 61-72
56. Totterdell S., and Meredith G.E. Localization of alpha-synuclein to identified fibers and synapses in the normal mouse brain. Neuroscience 135 (2005) 907-913
57. Uversky V.N. Alpha-synuclein misfolding and neurodegenerative diseases. Curr Protein Pept Sci 9 (2008) 507-540
58. Watkins-Chow D.E., and Pavan W.J. Genomic copy number and expression variation within the C57BL/6J inbred mouse strain. Genome Res 18 (2008) 60-66
59. Williams A., Lucassen P.J., Ritchie D., and Bruce M. PrP deposition, microglial activation, and neuronal apoptosis in murine scrapie. Exp Neurol 144 (1997) 433-438
60. Williams A.E., Lawson L.J., Perry V.H., and Fraser H. Characterization of the microglial response in murine scrapie. Neuropathol Appl Neurobiol 20 (1994) 47-55
61. Yu J., and Lyubchenko Y.L. Early stages for Parkinson's development: alpha-synuclein misfolding and aggregation. J Neuroimmune Pharmacol 4 (2009) 10-16
62. Yu S., Li X., Liu G., Han J., Zhang C., Li Y., Xu S., Liu C., Gao Y., Yang H., Ueda K., and Chan P. Extensive nuclear localization of alpha-synuclein in normal rat brain neurons revealed by a novel monoclonal antibody. Neuroscience 145 (2007) 539-555
63. Zarranz J.J., Alegre J., Gomez-Esteban J.C., Lezcano E., Ros R., Ampuero I., Vidal L., Hoenicka J., Rodriguez O., Atares B., Llorens V., Gomez Tortosa E., del Ser T., Munoz D.G., and de Yebenes J.G. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann Neurol 55 (2004) 164-173